FDA Drug Application (202487) for SITAGLIPTIN PHOSPHATE by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number202487
Product Number001
FormTABLET;ORAL
Dosage25MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSITAGLIPTIN PHOSPHATE
Active IngredientSITAGLIPTIN PHOSPHATE



Back to FDA Applications sponsored by TEVA PHARMS USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.